Amgen Inc. (VIE:AMGN)
Austria flag Austria · Delayed Price · Currency is EUR
289.85
-0.05 (-0.02%)
At close: Jan 29, 2026

Amgen Statistics

Total Valuation

Amgen has a market cap or net worth of EUR 154.34 billion. The enterprise value is 192.83 billion.

Market Cap154.34B
Enterprise Value 192.83B

Important Dates

The last earnings date was Tuesday, February 3, 2026.

Earnings Date Feb 3, 2026
Ex-Dividend Date Nov 21, 2025

Share Statistics

Current Share Class 538.48M
Shares Outstanding n/a
Shares Change (YoY) +0.19%
Shares Change (QoQ) +0.18%
Owned by Insiders (%) 0.15%
Owned by Institutions (%) 80.64%
Float 537.12M

Valuation Ratios

The trailing PE ratio is 23.50 and the forward PE ratio is 15.06.

PE Ratio 23.50
Forward PE 15.06
PS Ratio 4.93
PB Ratio 20.93
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio 18.20
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings 29.36
EV / Sales 6.20
EV / EBITDA 15.75
EV / EBIT 25.09
EV / FCF n/a

Financial Position

The company has a current ratio of 1.14, with a Debt / Equity ratio of 6.31.

Current Ratio 1.14
Quick Ratio 0.73
Debt / Equity 6.31
Debt / EBITDA 3.78
Debt / FCF n/a
Interest Coverage 3.30

Financial Efficiency

Return on equity (ROE) is 106.10% and return on invested capital (ROIC) is 14.33%.

Return on Equity (ROE) 106.10%
Return on Assets (ROA) 6.22%
Return on Invested Capital (ROIC) 14.33%
Return on Capital Employed (ROCE) 13.95%
Weighted Average Cost of Capital (WACC) n/a
Revenue Per Employee 1.12M
Profits Per Employee 234,552
Employee Count28,000
Asset Turnover 0.40
Inventory Turnover 1.82

Taxes

In the past 12 months, Amgen has paid 1.08 billion in taxes.

Income Tax 1.08B
Effective Tax Rate 14.09%

Stock Price Statistics

The stock price has increased by +5.44% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change +5.44%
50-Day Moving Average 285.53
200-Day Moving Average 259.63
Relative Strength Index (RSI) 55.24
Average Volume (20 Days) 62

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, Amgen had revenue of EUR 31.30 billion and earned 6.57 billion in profits. Earnings per share was 12.12.

Revenue31.30B
Gross Profit 21.05B
Operating Income 7.73B
Pretax Income 7.64B
Net Income 6.57B
EBITDA 12.32B
EBIT 7.73B
Earnings Per Share (EPS) 12.12
Full Income Statement

Balance Sheet

The company has 7.78 billion in cash and 46.51 billion in debt, with a net cash position of -38.73 billion.

Cash & Cash Equivalents 7.78B
Total Debt 46.51B
Net Cash -38.73B
Net Cash Per Share n/a
Equity (Book Value) 7.37B
Book Value Per Share 13.68
Working Capital 3.04B
Full Balance Sheet

Cash Flow

Operating Cash Flow 8.48B
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 67.25%, with operating and profit margins of 24.71% and 20.98%.

Gross Margin 67.25%
Operating Margin 24.71%
Pretax Margin 24.42%
Profit Margin 20.98%
EBITDA Margin 39.35%
EBIT Margin 24.71%
FCF Margin n/a

Dividends & Yields

This stock pays an annual dividend of 8.52, which amounts to a dividend yield of 2.94%.

Dividend Per Share 8.52
Dividend Yield 2.94%
Dividend Growth (YoY) 2.03%
Years of Dividend Growth 9
Payout Ratio n/a
Buyback Yield -0.19%
Shareholder Yield 2.75%
Earnings Yield 4.26%
FCF Yield n/a
Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 6